A Study to Assess the Effect of AZD4041 on Respiratory Drive in Recreational Opioid Users.

Trial Identifier:	D7460C00003
Sponsor:	AstraZeneca
NCTID::	NCT05587998
Start Date:	September 2022
Primary Completion Date:	May 2023
Study Completion Date:	May 2023

Available Languages

For questions about your Trial Results Summary, please see Sponsor contact section within your Trial Results Summary.

Language	Description
	English Version

Stay informed about new Trial Results Summaries with our email notification service

Trial Locations

Country	Location
US, KS	Overland Park, KS, US, 66212

Pharma Intelligence UK Limited is a company registered in England and Wales with company number 13787459 whose registered office is 3 More London Riverside, London SE1 2AQ.